Table 3.

E21R and MoAb cA2 Prevent Engraftment of JMML, But Not of Normal Bone Marrow Cells in SCID/NOD Mice

InterventionDonorCell Content in Mice Femoral Marrow (%)
Human XYHuman XXMouse
Untreated Normal female 0; 0; 0 56; 48; 51 44; 52; 49 
Untreated JMML male 78; 84; 80 0; 0; 0 21; 16; 20 
Untreated Normal female + JMML male 54; 49; 58 41; 39; 30 5; 12; 12 
E21R + cA2 Normal female 0; 0; 0 47; 63; 56 53; 37; 44 
E21R + cA2 JMML male 0; 0; 0 0; 0; 0 100; 100; 100 
E21R + cA2 Normal female + JMML male 0; 0; 0 53; 36; 47 47; 64; 53 
InterventionDonorCell Content in Mice Femoral Marrow (%)
Human XYHuman XXMouse
Untreated Normal female 0; 0; 0 56; 48; 51 44; 52; 49 
Untreated JMML male 78; 84; 80 0; 0; 0 21; 16; 20 
Untreated Normal female + JMML male 54; 49; 58 41; 39; 30 5; 12; 12 
E21R + cA2 Normal female 0; 0; 0 47; 63; 56 53; 37; 44 
E21R + cA2 JMML male 0; 0; 0 0; 0; 0 100; 100; 100 
E21R + cA2 Normal female + JMML male 0; 0; 0 53; 36; 47 47; 64; 53 

Mice were injected with bone marrow cells from either a healthy female donor, or from a male JMML patient, or with an equal mixture of normal and JMML cells. The mice were either left untreated or given a combined treatment with E21R and MoAb cA2 for 4 weeks from the time of transplantation. The fractions of human XY, XX, and mouse cells collected from mouse femoral marrow were quantitated using a fluorescent in situ hybridization. The values represent the percentage of 300 counted bone marrow cells. Data from three different mice are shown.

Close Modal

or Create an Account

Close Modal
Close Modal